Abzyme Therapeutics Company Profile, Contacts & Intelligence

Biotechnology Research321 Jones Boulevard8 employeesFounded 2010
2 contacts with email or phone data2 with email data2 with phone data
View verified contacts Compare competitors
Employees
8
Company source estimate
Reachable Contacts
2
Visible contacts with email or phone data
Contacts With Email
2
2 of 4 visible contacts

Abzyme Therapeutics Overview

Abzyme Therapeutics is a biopharmaceutical company focused on developing modular single domain VHH antibody fragments for immunotherapy using proprietary antibody generation platforms. The company is located in the Eastern Pennsylvania biotechnology/pharmaceutical hub 30-miles west of Philadelphia. Unique to Abzyme is our proprietary and highly engineered eukaryotic in vitro antibody discovery/optimization platform based on yeast display self-diversifying libraries, rapid target-directed antibody affinity maturation in combination with a FACS single cell sorting approach to identify desired antibodies. Abzyme’s modular antibody discovery platform incorporates a real-time screening ability to select for key properties such as epitopic diversity, binding affinity, expressibility, solubility, developability, broad-reactivity and target-specificity. Today, the Company has over 60 proprietary and partnered programs in development in therapeutic and diagnostic areas including infectious diseases, immuno-oncology, ophthalmology, inflammation and central nervous system disorders.

Headquarters
321 Jones Boulevard
Website
abzymetx.com
Industry
Biotechnology Research
Founded
2010
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Phone Number
Available in AeroLeads
Company Email
Available in AeroLeads
Antibody devlopment Antibody optimization Antibody engineering Antibody production Therapeutic antibody Bispecific Antibody T-cell engaging antibody Camelid VHH antibody Human recombinant antibody Single domain antibody Immunotherapy Human VH

Abzyme Therapeutics Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

2 contacts with contact data
2 with email data and 2 with phone data in the visible sample.

Abzyme Therapeutics People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

S
Steve Manobianco
Founder - Fractional Commercial Leader - Commercialization Strategist at Psg Life Sciences
EP
S
Samantha Moyer
J
James (Jim) Fendrick
President & CEO - Antibodies & Assays - Research Tools - Life Science - Biotechnology - C Level - Key Opinion Leader
H
Hiep Tran
Chief Scientific Officer - Antibody Discovery - Antibody Engineering - Immunotherapy - Entrepreneur
EP

Abzyme Therapeutics Workforce Composition

Seniority breakdown across 5 visible profiles.

Executive
3
Individual contributor
1
Associate / junior
1

Abzyme Therapeutics Technology & Talent

Technology-related job titles represented in the visible people data.

Data / AI
1
Engineering
1

Compare Similar Companies to Abzyme Therapeutics

Explore companies in related markets and compare their industry and employee estimates.

Company Industry / match Employee estimate Page
Rockland Immunochemicals, Inc. Biotechnology Research 108 View company
Interius BioTherapeutics Biotechnology Research 57 View company
OCMS Bio Biotechnology Research 16 View company
PSG Biotechnology Research 14 View company
Annovis Bio, Inc. Biotechnology Research 12 View company
Exeliom Biosciences Pharmaceutical Manufacturing 9 View company
Progenra, Inc. Biotechnology 9 View company
PulseSight Therapeutics Biotechnology Research 9 View company
20n Bio Biotechnology Research 5 View company
CytoEX Inc. Research 2 View company